Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Newer anti-seizure medicine for focal epilepsy. | Widely used, low-interaction epilepsy medicine. |
| Body system | Brain & Nerves | Brain & Nerves |
| Drug class | Antiseizure medicines | Antiseizure medicines |
| Supply | Prescription only | Prescription only |
| Main uses | Focal seizures, Generalised tonic-clonic seizures (add-on), Status epilepticus (IV, hospital) | Focal and generalised epilepsy, Status epilepticus (IV, second line), Myoclonic seizures |
| How it works | Calms overactive brain signals. | Calms excessive electrical activity in the brain. |
| Starts working | 1–4 hours | — |
| Half-life | About 13 hours | 6–8 hours |
| Typical adult dose | 50 mg twice a day, increased weekly to 100–200 mg twice a day. | 250–500 mg twice a day, increasing to 1,000–1,500 mg twice a day. |
| Forms | Tablet, Oral solution, IV infusion | Tablet, Oral solution, IV infusion, Granules |
| Common side effects | Dizziness, Headache, Nausea, Double vision, Unsteadiness | Sleepiness, Tiredness, Irritability, Dizziness |
| Serious side effects | Heart block and rhythm problems, Suicidal thoughts, Severe skin reactions (rare) | Depression, aggression or suicidal thoughts, Severe skin reactions (rare) |
| Don't take if | Second- or third-degree heart block | Allergy to levetiracetam; Severe kidney impairment (adjust dose) |
| Alcohol | Best to limit. Alcohol adds to dizziness. | Best to limit. Alcohol may lower the seizure threshold and add to drowsiness. |
| Pregnancy | Use with cautionLimited data; specialist advice needed. | Use with cautionOne of the lower-risk epilepsy medicines in pregnancy; plan with your specialist and take high-dose folic acid. |
| Breastfeeding | Use with cautionPasses into milk; monitor the baby. | Use with cautionPasses into milk; monitor the baby. |
| In use since | — | 1999 |
| Brand names | United States: VimpatUnited Kingdom: VimpatIndia: Lacosam, Vimpat | United States: Keppra, SpritamUnited Kingdom: Keppra, DesitrendIndia: Levipil, Levera, Levroxa |
| Legal status | United States: Schedule V controlled substanceUnited Kingdom: Controlled drug (Schedule 5)India: Prescription only (Schedule H) | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | N03AX18 | N03AX14 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker